02179.HK
Jiangsu Recbio Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 4.00
+0.00%Margins
Gross margin
-509.4%
EBITDA margin
-3842.5%
EBIT margin
-5001.3%
Net margin
-5134.3%
FCF margin
-5437.9%
-95.8%
Return on equity
-29.9%
Return on assets
-39.7%
Return on invested capital
0.01x
Asset turnover
-HKD 525.4M
Cash from operations
HKD 0.36
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026